{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T20:43:21Z","timestamp":1743021801277,"version":"3.40.3"},"publisher-location":"Cham","reference-count":32,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783031087509"},{"type":"electronic","value":"9783031087516"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/978-3-031-08751-6_27","type":"book-chapter","created":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T06:03:15Z","timestamp":1655791395000},"page":"375-388","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Exploring Ductal Carcinoma In-Situ to Invasive Ductal Carcinoma Transitions Using Energy Minimization Principles"],"prefix":"10.1007","author":[{"given":"Vivek M.","family":"Sheraton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shijun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,15]]},"reference":[{"key":"27_CR1","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3389\/fonc.2017.00248","volume":"7","author":"KL Gorringe","year":"2017","unstructured":"Gorringe, K.L., Fox, S.B.: Ductal carcinoma in situ biology, biomarkers, and diagnosis. Front Oncol 7, 248 (2017)","journal-title":"Front Oncol"},{"key":"27_CR2","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.molonc.2013.07.005","volume":"7","author":"CF Cowell","year":"2013","unstructured":"Cowell, C.F., et al.: Progression from ductal carcinoma in situ to invasive breast cancer: revisited. Mol Oncol 7, 859\u2013869 (2013)","journal-title":"Mol Oncol"},{"key":"27_CR3","doi-asserted-by":"publisher","first-page":"5974","DOI":"10.1073\/pnas.0931261100","volume":"100","author":"X-J Ma","year":"2003","unstructured":"Ma, X.-J., et al.: Gene expression profiles of human breast cancer progression. Proc. Natl. Acad. Sci. 100, 5974\u20135979 (2003)","journal-title":"Proc. Natl. Acad. Sci."},{"key":"27_CR4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/00019606-200003000-00003","volume":"9","author":"MM Aubele","year":"2000","unstructured":"Aubele, M.M., et al.: Accumulation of chromosomal imbalances from intraductal proliferative lesions to adjacent in situ and invasive ductal breast cancer. Diagn. Mol. Pathol. 9, 14\u201319 (2000)","journal-title":"Diagn. Mol. Pathol."},{"key":"27_CR5","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1073\/pnas.1200010109","volume":"109","author":"S Volinia","year":"2012","unstructured":"Volinia, S., et al.: Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA. Proc. Natl. Acad. Sci. 109, 3024\u20133029 (2012)","journal-title":"Proc. Natl. Acad. Sci."},{"key":"27_CR6","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1634\/theoncologist.12-11-1276","volume":"12","author":"JC Boughey","year":"2007","unstructured":"Boughey, J.C., Gonzalez, R.J., Bonner, E., Kuerer, H.M.: Current treatment and clinical trial developments for ductal carcinoma in situ of the breast. Oncologist 12, 1276\u20131287 (2007)","journal-title":"Oncologist"},{"key":"27_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1742-4682-11-29","volume":"11","author":"S Kurbel","year":"2014","unstructured":"Kurbel, S., Marjanovi\u0107, K., Dmitrovi\u0107, B.: A model of immunohistochemical differences between invasive breast cancers and DCIS lesions tested on a consecutive case series of 1248 patients. Theor. Biol. Med. Model. 11, 29 (2014)","journal-title":"Theor. Biol. Med. Model."},{"key":"27_CR8","doi-asserted-by":"crossref","unstructured":"Brentani: Concomitant expression of epithelial-mesenchymal transition biomarkers in breast ductal carcinoma: association with progression. Oncology Reports 23 (2009)","DOI":"10.3892\/or_00000638"},{"key":"27_CR9","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1136\/jcp.55.6.461","volume":"55","author":"T Megha","year":"2002","unstructured":"Megha, T., et al.: p53 mutation in breast cancer. Correlation with cell kinetics and cell of origin. J. Clin. Pathol. 55, 461\u2013466 (2002)","journal-title":"J. Clin. Pathol."},{"key":"27_CR10","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.ccr.2007.10.017","volume":"12","author":"ML Gauthier","year":"2007","unstructured":"Gauthier, M.L., et al.: Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and defines basal-like breast tumors. Cancer Cell 12, 479\u2013491 (2007)","journal-title":"Cancer Cell"},{"key":"27_CR11","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.ajpath.2011.05.043","volume":"179","author":"AK Witkiewicz","year":"2011","unstructured":"Witkiewicz, A.K., et al.: Association of RB\/p16-pathway perturbations with DCIS recurrence: dependence on tumor versus tissue microenvironment. Am. J. Pathol. 179, 1171\u20131178 (2011)","journal-title":"Am. J. Pathol."},{"key":"27_CR12","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.humpath.2017.04.007","volume":"68","author":"X Wang","year":"2017","unstructured":"Wang, X., et al.: p53 alteration in morphologically normal\/benign breast luminal cells in BRCA carriers with or without history of breast cancer. Hum Pathol 68, 22\u201325 (2017)","journal-title":"Hum Pathol"},{"key":"27_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003027","volume":"8","author":"P Kumar","year":"2012","unstructured":"Kumar, P., et al.: Cooperativity of Rb, Brca1, and p53 in malignant breast cancer evolution. PLoS Genet. 8, e1003027 (2012)","journal-title":"PLoS Genet."},{"key":"27_CR14","doi-asserted-by":"crossref","unstructured":"Palm, M.M., Merks, R.M.: Large-scale parameter studies of cell-based models of tissue morphogenesis using CompuCell3D or VirtualLeaf. Tissue Morphogenesis: Methods and Protocols 301\u2013322 (2015)","DOI":"10.1007\/978-1-4939-1164-6_20"},{"key":"27_CR15","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1006\/bulm.1998.0042","volume":"60","author":"AR Anderson","year":"1998","unstructured":"Anderson, A.R., Chaplain, M.: Continuous and discrete mathematical models of tumor-induced angiogenesis. Bull. Math. Biol. 60, 857\u2013899 (1998)","journal-title":"Bull. Math. Biol."},{"key":"27_CR16","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/bib\/bbm024","volume":"8","author":"BC Thorne","year":"2007","unstructured":"Thorne, B.C., Bailey, A.M., Peirce, S.M.: Combining experiments with multi-cell agent-based modeling to study biological tissue patterning. Brief. Bioinform. 8, 245\u2013257 (2007)","journal-title":"Brief. Bioinform."},{"key":"27_CR17","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1007\/s10439-007-9266-1","volume":"35","author":"AM Bailey","year":"2007","unstructured":"Bailey, A.M., Thorne, B.C., Peirce, S.M.: Multi-cell agent-based simulation of the microvasculature to study the dynamics of circulating inflammatory cell trafficking. Ann. Biomed. Eng. 35, 916\u2013936 (2007)","journal-title":"Ann. Biomed. Eng."},{"key":"27_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0143206","volume":"10","author":"M Qiao","year":"2015","unstructured":"Qiao, M., Wu, D., Carey, M., Zhou, X., Zhang, L.: Multi-scale agent-based multiple myeloma cancer modeling and the related study of the balance between osteoclasts and osteoblasts. PLoS ONE 10, e0143206 (2015)","journal-title":"PLoS ONE"},{"key":"27_CR19","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/1471-2105-13-218","volume":"13","author":"X Sun","year":"2012","unstructured":"Sun, X., Zhang, L., Tan, H., Bao, J., Strouthos, C., Zhou, X.: Multi-scale agent-based brain cancer modeling and prediction of TKI treatment response: incorporating EGFR signaling pathway and angiogenesis. BMC Bioinformatics 13, 218 (2012)","journal-title":"BMC Bioinformatics"},{"key":"27_CR20","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jtbi.2012.02.002","volume":"301","author":"P Macklin","year":"2012","unstructured":"Macklin, P., Edgerton, M.E., Thompson, A.M., Cristini, V.: Patient-calibrated agent-based modelling of ductal carcinoma in situ (DCIS): from microscopic measurements to macroscopic predictions of clinical progression. J. Theor. Biol. 301, 122\u2013140 (2012)","journal-title":"J. Theor. Biol."},{"key":"27_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1003997","volume":"10","author":"E Boghaert","year":"2014","unstructured":"Boghaert, E., Radisky, D.C., Nelson, C.M.: Lattice-based model of ductal carcinoma in situ suggests rules for breast cancer progression to an invasive state. PLoS Comput. Biol. 10, e1003997 (2014)","journal-title":"PLoS Comput. Biol."},{"key":"27_CR22","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/B978-0-12-388403-9.00013-8","volume":"110","author":"MH Swat","year":"2012","unstructured":"Swat, M.H., Thomas, G.L., Belmonte, J.M., Shirinifard, A., Hmeljak, D., Glazier, J.A.: Multi-scale modeling of tissues using CompuCell 3D. Methods Cell Biol. 110, 325\u2013366 (2012)","journal-title":"Methods Cell Biol."},{"key":"27_CR23","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1080\/10715760600911303","volume":"40","author":"SI Rattan","year":"2006","unstructured":"Rattan, S.I.: Theories of biological aging: genes, proteins, and free radicals. Free Radical Res. 40, 1230\u20131238 (2006)","journal-title":"Free Radical Res."},{"key":"27_CR24","doi-asserted-by":"publisher","first-page":"329","DOI":"10.5306\/wjco.v2.i9.329","volume":"2","author":"JD Davis","year":"2011","unstructured":"Davis, J.D., Lin, S.-Y.: DNA damage and breast cancer. World J. Clin. Oncol. 2, 329\u2013338 (2011)","journal-title":"World J. Clin. Oncol."},{"key":"27_CR25","unstructured":"Gawe\u0142-B\u0119ben, K., et al.: TMEFF2 shedding is regulated by oxidative stress and mediated by ADAMs and transmembrane serine proteases implicated in prostate cancer. Cell Biology International n\/a-n\/a"},{"key":"27_CR26","doi-asserted-by":"publisher","first-page":"20140640","DOI":"10.1098\/rsif.2014.0640","volume":"11","author":"K-A Norton","year":"2014","unstructured":"Norton, K.-A., Popel, A.S.: An agent-based model of cancer stem cell initiated avascular tumour growth and metastasis: the effect of seeding frequency and location. J. R. Soc. Interface 11, 20140640 (2014)","journal-title":"J. R. Soc. Interface"},{"key":"27_CR27","doi-asserted-by":"publisher","first-page":"5220","DOI":"10.1038\/sj.onc.1209615","volume":"25","author":"C Giacinti","year":"2006","unstructured":"Giacinti, C., Giordano, A.: RB and cell cycle progression. Oncogene 25, 5220\u20135227 (2006)","journal-title":"Oncogene"},{"key":"27_CR28","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1111\/j.1349-7006.2004.tb02195.x","volume":"95","author":"K Yoshida","year":"2004","unstructured":"Yoshida, K., Miki, Y.: Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage. Cancer Sci. 95, 866\u2013871 (2004)","journal-title":"Cancer Sci."},{"key":"27_CR29","doi-asserted-by":"publisher","first-page":"9030","DOI":"10.1038\/sj.onc.1207116","volume":"22","author":"JS Fridman","year":"2003","unstructured":"Fridman, J.S., Lowe, S.W.: Control of apoptosis by p53. Oncogene 22, 9030 (2003)","journal-title":"Oncogene"},{"issue":"1","key":"27_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10544-017-0151-x","volume":"19","author":"EA Corbin","year":"2017","unstructured":"Corbin, E.A., Adeniba, O.O., Cangellaris, O.V., King, W.P., Bashir, R.: Evidence of differential mass change rates between human breast cancer cell lines in culture. Biomed. Microdevice 19(1), 1\u20137 (2017). https:\/\/doi.org\/10.1007\/s10544-017-0151-x","journal-title":"Biomed. Microdevice"},{"key":"27_CR31","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1093\/toxsci\/kfg154","volume":"75","author":"SL Starcevic","year":"2003","unstructured":"Starcevic, S.L., Diotte, N.M., Zukowski, K.L., Cameron, M.J., Novak, R.F.: Oxidative DNA damage and repair in a cell lineage model of human proliferative breast disease (PBD). Toxicol. Sci. 75, 74\u201381 (2003)","journal-title":"Toxicol. Sci."},{"key":"27_CR32","doi-asserted-by":"crossref","unstructured":"Knudsen, E.S., et al.: Retinoblastoma and phosphate and tensin homolog tumor suppressors: impact on ductal carcinoma in situ progression. JNCI: J. Natl. Can. Inst. 104, 1825\u20131836 (2012)","DOI":"10.1093\/jnci\/djs446"}],"container-title":["Lecture Notes in Computer Science","Computational Science \u2013 ICCS 2022"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-08751-6_27","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T06:06:28Z","timestamp":1655791588000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-08751-6_27"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9783031087509","9783031087516"],"references-count":32,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-08751-6_27","relation":{},"ISSN":["0302-9743","1611-3349"],"issn-type":[{"type":"print","value":"0302-9743"},{"type":"electronic","value":"1611-3349"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"15 June 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"ICCS","order":1,"name":"conference_acronym","label":"Conference Acronym","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"International Conference on Computational Science","order":2,"name":"conference_name","label":"Conference Name","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"London","order":3,"name":"conference_city","label":"Conference City","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"United Kingdom","order":4,"name":"conference_country","label":"Conference Country","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"2022","order":5,"name":"conference_year","label":"Conference Year","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"21 June 2022","order":7,"name":"conference_start_date","label":"Conference Start Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"23 June 2022","order":8,"name":"conference_end_date","label":"Conference End Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"22","order":9,"name":"conference_number","label":"Conference Number","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"iccs-computsci2022","order":10,"name":"conference_id","label":"Conference ID","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"https:\/\/www.iccs-meeting.org\/iccs2022\/","order":11,"name":"conference_url","label":"Conference URL","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Single-blind","order":1,"name":"type","label":"Type","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"EasyChair","order":2,"name":"conference_management_system","label":"Conference Management System","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"474","order":3,"name":"number_of_submissions_sent_for_review","label":"Number of Submissions Sent for Review","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"175","order":4,"name":"number_of_full_papers_accepted","label":"Number of Full Papers Accepted","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"78","order":5,"name":"number_of_short_papers_accepted","label":"Number of Short Papers Accepted","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"37% - The value is computed by the equation \"Number of Full Papers Accepted \/ Number of Submissions Sent for Review * 100\" and then rounded to a whole number.","order":6,"name":"acceptance_rate_of_full_papers","label":"Acceptance Rate of Full Papers","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"2.8","order":7,"name":"average_number_of_reviews_per_paper","label":"Average Number of Reviews per Paper","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"3","order":8,"name":"average_number_of_papers_per_reviewer","label":"Average Number of Papers per Reviewer","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"Yes","order":9,"name":"external_reviewers_involved","label":"External Reviewers Involved","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}}]}}